Early phase II study of amrubicin (SM-5887) for superficial bladder cancer: a dose-finding study for intravesical chemotherapy

Gan to kagaku ryoho. Cancer & chemotherapy

Volumn 28, Issue 4, 2001, Pages 483-491

  Tsushima, T ^a   Kobashi, K ^a   Akebi, N ^a   Yamato, T ^a   Asahi, T ^a   Maki, Y ^a   Ohmori, H ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMRUBICIN; ANTHRACYCLINE; ANTINEOPLASTIC AGENT;

AGED; ARTICLE; BLADDER TUMOR; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; FEMALE; HEMATURIA; HUMAN; INTRAVESICAL DRUG ADMINISTRATION; MALE; MICTURITION; MIDDLE AGED; MULTICENTER STUDY; PAIN; PATHOPHYSIOLOGY; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, INTRAVESICAL; AGED; ANTHRACYCLINES; ANTINEOPLASTIC AGENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMATURIA; HUMANS; MALE; MIDDLE AGED; PAIN; URINARY BLADDER NEOPLASMS; URINATION;

EID: 0035320690     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)